Please login to the form below

Not currently logged in
Email:
Password:

ALK-Abello appoints Søren Jelert as CFO

He will be based at the company’s headquarters in Denmark

Soren JelertDansih allergy immunotherapy company ALK-Abello has appointed Søren Jelert as its new chief financial officer, a role that sees him succeed Flemming Pederson at the pharmaceutical company.

Jelert most recently served as a general manager for NNE, an engineering company that specialises in supporting pharmaceutical company engineering projects.

He said: “This new role offers me the opportunity to use my knowledge and experience to support and further develop ALK as it works to build a new growth platform and to become a truly global allergy company.”

His career has seen him serve in various capacities for Novo Nordisk, including as finance director Europe North and manager operations, finance.

Carsten Hellmann, president and chief executive officer, ALK, said: “Søren brings a wealth of experience to ALK, in particular from his previous pharmaceutical industry-focused roles at NNE and Novo Nordisk.

“He has a proven track record of financial leadership and he has also played a pivotal role in transformation processes that are comparable to the one we are embarking upon at ALK.”

Jelert will be based at ALK’s headquarters in Hørsholm, Denmark and will report directly to Hellmann.

11th December 2017

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics